Overview Financials News + Filings
|
|
Curative Biotechnology Inc
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Jun-30-21 | Dec-31-20 | Jun-30-20 |
| | S-1/A | S-1 | S-1/A | | S-1 | | |
| Assets |
| Cash and equivalents | 0.0 | 0.1 | 0.3 | | 670.3 | | |
| Other current assets | 0.0 | 0.1 | 0.1 | | 83.6 | | |
| Total current assets | 0.0 | 0.2 | 0.4 | | 753.9 | | |
| Property, plant, and equipment, net | 0.0 | 0.0 | 0.0 | | 6.9 | | |
| Intangibles | | | | | 1,558.6 | | |
| Other fixed assets | 2.0 | 1.8 | 1.8 | | 1,651.5 | | |
| Total assets | 2.0 | 2.0 | 2.2 | | 2,412.2 | | |
| |
| Short-term debt | 0.6 | 0.4 | 0.2 | | 0.0 | | |
| Short-term debt | 0.6 | 0.4 | 0.2 | | | | |
| Other current liabilities | 2.4 | 1.6 | 0.7 | | 730.3 | | |
| Total current liabilities | 3.1 | 1.9 | 0.8 | | 730.3 | | |
| Total liabilities | 3.1 | 1.9 | 0.8 | | 730.3 | | |
| |
| Shareholders' equity [+] | -1.1 | 0.1 | 1.4 | | 1,681.8 | | |
| Paid-in capital | 11.9 | 11.6 | 11.6 | | 10,498.2 | | |
| Retained earnings | -31.0 | -29.6 | -28.3 | | -26,917.0 | | |
| Tangible shareholders' equity | -1.1 | 0.1 | 1.4 | | 123.3 | | |
|